Chapter 19: Palliative Care and End-of-Life Care: Multiple Choice
Chapter 19: Palliative Care and End-of-Life Care: Multiple Choice
Chapter 19: Palliative Care and End-of-Life Care: Multiple Choice
Multiple Choice
Identify the choice that best completes the statement or answers the question.
____ 2. Evidence reflects the primary obstacle to implementing palliative care in the long-term care setting
include all of the following except:
A. Inadequate communication between decision makers
B. Failure to recognize futile treatments
C. Lack of advance directives
D. Lack of sufficient staff
____ 3. The most prevalent symptom in end-of-life care includes all of the following except:
A. Lower extremity weakness
B. Pain
C. Dyspnea
D. Delirium
____ 4. Pain at the end of life is most often due to all of the following except:
A. Musculoskeletal disorders
B. Headache
C. Cancer pain
D. Neuropathic pain
____ 5. The strongest level of evidence reflects the absolute contraindication for NSAID use exists with:
A. Chronic kidney disease
B. Peptic ulcer disease
C. Heart disease
D. Liver disease
____ 7. Pharmacological interventions for dyspnea include all of the following except:
A. Antitussives
B. Inhaled anesthetics
C. Sedatives
D. Anxiolytics
____ 8. Delirium is typically characterized by all of the following except:
A. Inattention
B. Hyperactive level of psychomotor activity
C. Disorganized thinking
D. Altered level of consciousness
____ 11. A drug that can be used to treat two very common symptoms in a dying patient (pain and dyspnea)
is:
A. Morphine
B. Methadone
C. Gabapentin
D. Lorazepam
____ 12. The tasks of grieving include all of the following except:
A. Acknowledge the reality of death
B. Work through the pain of grief
C. Begin to disengage
D. Restructure relationships
____ 14. All of the following statements are true about interventions in working with the bereaved except:
A. Allow the active expression of grief
B. There is strong evidence behind recommended interventions
C. Staff attending memorial services support the family
D. Provide both emotional and spiritual support
____ 15. The highest level of evidence to support interventions at the end of life is with:
A. Opioids for pain control
B. Hyocsyamine for respiratory secretions
C. Stimulant laxatives for treating constipation
D. Opioids for dyspnea
____ 16. The highest level of evidence with the use of adjuvant analgesics is with:
A. Tricyclic antidepressants avoided due to high adverse events
B. Therapeutic trials before discontinuing drugs
C. Patient with fibromyalgia are candidates for adjuvant analgesics
D. Neuropathic pain patients are candidates for adjuvant analgesia
Chapter 19: Palliative Care and End-of-Life Care
Answer Section
MULTIPLE CHOICE
1. ANS: B PTS: 1
2. ANS: D PTS: 1
3. ANS: A PTS: 1
4. ANS: B PTS: 1
5. ANS: A PTS: 1
6. ANS: D PTS: 1
7. ANS: C PTS: 1
8. ANS: B PTS: 1
9. ANS: B PTS: 1
10. ANS: D PTS: 1
11. ANS: A PTS: 1
12. ANS: C PTS: 1
13. ANS: A PTS: 1
14. ANS: B PTS: 1
15. ANS: D PTS: 1
16. ANS: D PTS: 1